BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17041948)

  • 21. Direct-to-vial comparison of a new liquid-based cytology system, liqui-PREP versus the conventional pap smear.
    Park J; Jung EH; Kim C; Choi YH
    Diagn Cytopathol; 2007 Aug; 35(8):488-92. PubMed ID: 17636495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organisation of cervical cytology screening in Croatia: past, present and future.
    Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
    Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid, high throughput determination of cervical cytology specimen adequacy using a capillary-based cytometer.
    Polina R; Sturgis C; Patterson J; Patterson BK
    Cytometry B Clin Cytom; 2008 Mar; 74(2):133-6. PubMed ID: 18044721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of agreement between conventional and liquid-based cytology in cervical cancer early detection based on analysis of 2,091 smears: experience at the Brazilian National Cancer Institute.
    Girianelli VR; Santos Thuler LC
    Diagn Cytopathol; 2007 Sep; 35(9):545-9. PubMed ID: 17703446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia.
    Wentzensen N; Bergeron C; Cas F; Vinokurova S; von Knebel Doeberitz M
    Cancer; 2007 Feb; 111(1):58-66. PubMed ID: 17186505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
    Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeating cytological preparations on liquid-based cytology samples: A methodological advantage?
    Pinto AP; Maia HF; di Loretto C; Krunn P; Túlio S; Collaço LM
    Diagn Cytopathol; 2007 Oct; 35(10):663-9. PubMed ID: 17854084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid based cytology: a new cervical screening system for the UK.
    Wall A
    J Fam Health Care; 2005; 15(3):90-2. PubMed ID: 16094904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid-based cervical cytology tests.
    Sulik SM; Becker LA; Grant WD
    J Fam Pract; 2002 Apr; 51(4):378. PubMed ID: 11978265
    [No Abstract]   [Full Text] [Related]  

  • 37. Population screening for cervical carcinoma in the Borough of Frederiksberg.
    Koch F; Stakemann G
    Acta Obstet Gynecol Scand; 1967; 46():Suppl 9:77-84. PubMed ID: 6075717
    [No Abstract]   [Full Text] [Related]  

  • 38. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears?
    Moseley R
    Cytopathology; 2002 Apr; 13(2):135-6. PubMed ID: 11952756
    [No Abstract]   [Full Text] [Related]  

  • 39. The advantages of incorporating liquid-based cytology (TACAS™) in mass screening for cervical cancer.
    Yokoyama Y; Futagami M; Watanabe J; Sakuraba A; Nagasawa K; Maruyama H; Sato S
    Hum Cell; 2016 Apr; 29(2):83-90. PubMed ID: 26739336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of liquid-based cytology in the screening programme against cervical cancer in the County of Funen, Denmark, and status for the first year.
    Hoelund B
    Cytopathology; 2003 Oct; 14(5):269-74. PubMed ID: 14510891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.